whi p154 has been researched along with Neoplasms in 1 studies
WHI P154: an anti-leukemic agent; structure in first source
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sudbeck, EA | 1 |
Ghosh, S | 1 |
Liu, XP | 1 |
Zheng, Y | 1 |
Myers, DE | 1 |
Uckun, FM | 1 |
1 review available for whi p154 and Neoplasms
Article | Year |
---|---|
Tyrosine kinase inhibitors against EGF receptor-positive malignancies.
Topics: Adenocarcinoma; Amides; Aniline Compounds; Animals; Antineoplastic Agents; Breast Neoplasms; Drug De | 2001 |